406 related articles for article (PubMed ID: 26412163)
1. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
[TBL] [Abstract][Full Text] [Related]
2. Immunocompromised status in patients with necrotizing soft-tissue infection.
Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R
JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a necrotizing soft-tissue infection mortality risk calculator using NSQIP.
Faraklas I; Stoddard GJ; Neumayer LA; Cochran A
J Am Coll Surg; 2013 Jul; 217(1):153-160.e3; discussion 160-1. PubMed ID: 23628224
[TBL] [Abstract][Full Text] [Related]
4. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12.
Audureau E; Hua C; de Prost N; Hemery F; Decousser JW; Bosc R; Lepeule R; Chosidow O; Sbidian E;
Br J Dermatol; 2017 Dec; 177(6):1575-1582. PubMed ID: 28452064
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing soft tissue infections: improved outcomes with modern care.
Tillou A; St Hill CR; Brown C; Velmahos G
Am Surg; 2004 Oct; 70(10):841-4. PubMed ID: 15534961
[TBL] [Abstract][Full Text] [Related]
6. Necrotizing Soft Tissue Infections at a Tertiary Referral Hospital in Rwanda: Epidemiology and Risk Factors for Mortality.
Mpirimbanyi C; Rickard J; Furaha C; Ntirenganya F
World J Surg; 2018 Aug; 42(8):2314-2320. PubMed ID: 29417246
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
8. Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections.
Beauchamp LC; Mostafavifar LG; Evans DC; Gerlach AT
Surg Infect (Larchmt); 2019; 20(4):305-310. PubMed ID: 30716012
[No Abstract] [Full Text] [Related]
9. Characteristics and differences in necrotizing fasciitis and gas forming myonecrosis: a series of 36 patients.
Tilkorn DJ; Citak M; Fehmer T; Ring A; Hauser J; Al Benna S; Steinstraesser L; Roetman B; Steinau HU
Scand J Surg; 2012; 101(1):51-5. PubMed ID: 22414469
[TBL] [Abstract][Full Text] [Related]
10. Are we getting necrotizing soft tissue infections right? A 10-year review.
Proud D; Bruscino Raiola F; Holden D; Paul E; Capstick R; Khoo A
ANZ J Surg; 2014 Jun; 84(6):468-72. PubMed ID: 24164901
[TBL] [Abstract][Full Text] [Related]
11. A Multi-Center Review of Care Patterns and Outcomes in Necrotizing Soft Tissue Infections.
Faraklas I; Yang D; Eggerstedt M; Zhai Y; Liebel P; Graves G; Dissanaike S; Mosier M; Cochran A
Surg Infect (Larchmt); 2016 Dec; 17(6):773-778. PubMed ID: 27834617
[TBL] [Abstract][Full Text] [Related]
12. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
[TBL] [Abstract][Full Text] [Related]
13. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
Front Immunol; 2020; 11():17. PubMed ID: 32082310
[No Abstract] [Full Text] [Related]
14. Epidemiology and Outcomes of Hospitalized Children With Necrotizing Soft-Tissue Infections.
Totapally BR
Pediatr Infect Dis J; 2017 Jul; 36(7):641-644. PubMed ID: 28005689
[TBL] [Abstract][Full Text] [Related]
15. The microbiology of necrotizing soft tissue infections.
Elliott D; Kufera JA; Myers RA
Am J Surg; 2000 May; 179(5):361-6. PubMed ID: 10930480
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality and limb loss in necrotizing soft tissue infections.
Anaya DA; McMahon K; Nathens AB; Sullivan SR; Foy H; Bulger E
Arch Surg; 2005 Feb; 140(2):151-7; discussion 158. PubMed ID: 15723996
[TBL] [Abstract][Full Text] [Related]
17. The impact of diabetes in patients with necrotizing soft tissue infections.
Kao LS; Knight MT; Lally KP; Mercer DW
Surg Infect (Larchmt); 2005; 6(4):427-38. PubMed ID: 16433607
[TBL] [Abstract][Full Text] [Related]
18. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity.
Kobayashi L; Konstantinidis A; Shackelford S; Chan LS; Talving P; Inaba K; Demetriades D
J Trauma; 2011 Nov; 71(5):1400-5. PubMed ID: 21768906
[TBL] [Abstract][Full Text] [Related]
19. Can progression of odontogenic infections to cervical necrotizing soft tissue infections be predicted?
Zemplenyi K; Lopez B; Sardesai M; Dillon JK
Int J Oral Maxillofac Surg; 2017 Feb; 46(2):181-188. PubMed ID: 27756512
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
